Topotecan Hydrochloride Patent Expiration
Topotecan Hydrochloride is Used for treating metastatic carcinoma of the ovary after failure of initial or subsequent chemotherapy. It was first introduced by Sandoz Inc
Topotecan Hydrochloride Patents
Given below is the list of patents protecting Topotecan Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Hycamtin | US5674872 | Treatment of ovarian cancer |
Oct 07, 2014
(Expired) | Sandoz |
| Hycamtin |
US5674872 (Pediatric) | Treatment of ovarian cancer |
Apr 07, 2015
(Expired) | Sandoz |
| Hycamtin | US8158645 | Compound, corresponding compositions, preparation and/or treatment methods | Dec 10, 2024 | Sandoz |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Topotecan Hydrochloride Generics
Several generic applications have been filed for Topotecan Hydrochloride. The first generic version for Topotecan Hydrochloride was by Fresenius Kabi Usa Llc and was approved on Nov 29, 2010. And the latest generic version is by Dash Pharmaceuticals Llc and was approved on Nov 24, 2017.
Given below is the list of companies who have filed for Topotecan Hydrochloride generic.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 3 different strengths of generic version for Topotecan Hydrochloride. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE/VIAL | injectable | Prescription | INJECTION | AP | Jun 26, 2013 |
| EQ 1MG BASE/ML (EQ 1MG BASE/ML) | solution | Prescription | INTRAVENOUS | N/A | Jul 6, 2017 |
| EQ 4MG BASE/4ML (EQ 1MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | Jul 6, 2017 |
2. SAGENT PHARMS
Sagent Pharmaceuticals Inc has filed for 1 generic for Topotecan Hydrochloride. Given below are the details of the strengths of this generic introduced by Sagent Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE/VIAL | injectable | Prescription | INJECTION | AP | Jan 26, 2011 |
3. TEYRO LABS
Teyro Labs Private Ltd has filed for 1 generic for Topotecan Hydrochloride. Given below are the details of the strengths of this generic introduced by Teyro Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE/VIAL | injectable | Prescription | INJECTION | AP | Dec 1, 2010 |
4. RISING
Rising Pharma Holdings Inc has filed for 1 generic for Topotecan Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE/VIAL | injectable | Discontinued | INJECTION | N/A | Aug 28, 2012 |
5. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 1 generic for Topotecan Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE/VIAL | injectable | Prescription | INJECTION | AP | Mar 9, 2011 |
6. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 1 generic for Topotecan Hydrochloride. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE/VIAL | injectable | Prescription | INJECTION | AP | Nov 29, 2010 |
7. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Topotecan Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE/VIAL | injectable | Discontinued | INJECTION | N/A | Aug 29, 2013 |
8. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 1 generic for Topotecan Hydrochloride. Given below are the details of the strengths of this generic introduced by Meitheal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE/VIAL | injectable | Discontinued | INJECTION | N/A | Aug 8, 2012 |
9. NOVAST LABS
Novast Laboratories Ltd has filed for 1 generic for Topotecan Hydrochloride. Given below are the details of the strengths of this generic introduced by Novast Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE/VIAL | injectable | Prescription | INJECTION | AP | Nov 30, 2016 |
10. ACTAVIS TOTOWA
Actavis Totowa Llc has filed for 1 generic for Topotecan Hydrochloride. Given below are the details of the strengths of this generic introduced by Actavis Totowa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE/VIAL | injectable | Prescription | INJECTION | AP | Dec 2, 2010 |
11. DASH PHARMS
Dash Pharmaceuticals Llc has filed for 1 generic for Topotecan Hydrochloride. Given below are the details of the strengths of this generic introduced by Dash Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE/4ML (EQ 1MG BASE/ML) | solution | Discontinued | INTRAVENOUS | N/A | Nov 24, 2017 |